nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.0767	0.1	CbGbCtD
Pravastatin—ABCG2—Leflunomide—systemic scleroderma	0.0574	0.0749	CbGbCtD
Pravastatin—SLC16A1—Methotrexate—systemic scleroderma	0.0551	0.0719	CbGbCtD
Pravastatin—CYP2C8—Mometasone—systemic scleroderma	0.0475	0.0619	CbGbCtD
Pravastatin—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0446	0.0583	CbGbCtD
Pravastatin—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0392	0.0512	CbGbCtD
Pravastatin—SLCO1A2—Prednisone—systemic scleroderma	0.0378	0.0494	CbGbCtD
Pravastatin—SLC22A6—Captopril—systemic scleroderma	0.0365	0.0476	CbGbCtD
Pravastatin—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0355	0.0463	CbGbCtD
Pravastatin—SLCO1B3—Methotrexate—systemic scleroderma	0.0307	0.0401	CbGbCtD
Pravastatin—SLC22A11—Methotrexate—systemic scleroderma	0.0284	0.0371	CbGbCtD
Pravastatin—SLC22A7—Methotrexate—systemic scleroderma	0.0271	0.0353	CbGbCtD
Pravastatin—ABCB1—Lisinopril—systemic scleroderma	0.0217	0.0283	CbGbCtD
Pravastatin—CYP2C9—Leflunomide—systemic scleroderma	0.0213	0.0278	CbGbCtD
Pravastatin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0197	0.0256	CbGbCtD
Pravastatin—SLCO1A2—Methotrexate—systemic scleroderma	0.019	0.0248	CbGbCtD
Pravastatin—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0189	0.0247	CbGbCtD
Pravastatin—SLCO1B1—Methotrexate—systemic scleroderma	0.0179	0.0234	CbGbCtD
Pravastatin—SLC22A8—Methotrexate—systemic scleroderma	0.0165	0.0216	CbGbCtD
Pravastatin—ABCB1—Captopril—systemic scleroderma	0.0162	0.0212	CbGbCtD
Pravastatin—ABCC2—Methotrexate—systemic scleroderma	0.0157	0.0205	CbGbCtD
Pravastatin—CYP2D6—Captopril—systemic scleroderma	0.0153	0.02	CbGbCtD
Pravastatin—ABCG2—Methotrexate—systemic scleroderma	0.0142	0.0186	CbGbCtD
Pravastatin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0128	0.0167	CbGbCtD
Pravastatin—SLC22A6—Methotrexate—systemic scleroderma	0.0115	0.015	CbGbCtD
Pravastatin—ABCB1—Prednisone—systemic scleroderma	0.0102	0.0133	CbGbCtD
Pravastatin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00766	0.01	CbGbCtD
Pravastatin—CYP2C9—cardial valve—systemic scleroderma	0.00646	0.311	CbGeAlD
Pravastatin—CYP3A4—Prednisone—systemic scleroderma	0.00613	0.00799	CbGbCtD
Pravastatin—ABCB1—Methotrexate—systemic scleroderma	0.00513	0.00669	CbGbCtD
Pravastatin—ABCB11—digestive system—systemic scleroderma	0.000825	0.0397	CbGeAlD
Pravastatin—HMGCR—connective tissue—systemic scleroderma	0.0008	0.0385	CbGeAlD
Pravastatin—SLCO1B3—lung—systemic scleroderma	0.000799	0.0385	CbGeAlD
Pravastatin—SLC22A11—digestive system—systemic scleroderma	0.000762	0.0367	CbGeAlD
Pravastatin—SLC22A7—digestive system—systemic scleroderma	0.000744	0.0358	CbGeAlD
Pravastatin—HMGCR—smooth muscle tissue—systemic scleroderma	0.000732	0.0352	CbGeAlD
Pravastatin—HMGCR—skin of body—systemic scleroderma	0.000722	0.0348	CbGeAlD
Pravastatin—HMGCR—digestive system—systemic scleroderma	0.000578	0.0278	CbGeAlD
Pravastatin—SLC16A1—digestive system—systemic scleroderma	0.000569	0.0274	CbGeAlD
Pravastatin—SLCO1B1—digestive system—systemic scleroderma	0.000553	0.0267	CbGeAlD
Pravastatin—HMGCR—tendon—systemic scleroderma	0.00055	0.0265	CbGeAlD
Pravastatin—SLC16A1—tendon—systemic scleroderma	0.000541	0.0261	CbGeAlD
Pravastatin—SLCO2B1—digestive system—systemic scleroderma	0.000489	0.0236	CbGeAlD
Pravastatin—HMGCR—lung—systemic scleroderma	0.000482	0.0232	CbGeAlD
Pravastatin—SLC16A1—lung—systemic scleroderma	0.000475	0.0229	CbGeAlD
Pravastatin—SLCO2B1—tendon—systemic scleroderma	0.000466	0.0224	CbGeAlD
Pravastatin—SLCO1A2—digestive system—systemic scleroderma	0.00045	0.0217	CbGeAlD
Pravastatin—ABCC2—digestive system—systemic scleroderma	0.00042	0.0202	CbGeAlD
Pravastatin—SLCO2B1—lung—systemic scleroderma	0.000409	0.0197	CbGeAlD
Pravastatin—ABCB1—blood vessel—systemic scleroderma	0.000407	0.0196	CbGeAlD
Pravastatin—ABCC2—tendon—systemic scleroderma	0.000399	0.0192	CbGeAlD
Pravastatin—SLCO1A2—lung—systemic scleroderma	0.000376	0.0181	CbGeAlD
Pravastatin—CYP3A5—digestive system—systemic scleroderma	0.000284	0.0137	CbGeAlD
Pravastatin—CYP2C9—digestive system—systemic scleroderma	0.00028	0.0135	CbGeAlD
Pravastatin—ABCG2—lung—systemic scleroderma	0.000256	0.0123	CbGeAlD
Pravastatin—CYP3A5—lung—systemic scleroderma	0.000237	0.0114	CbGeAlD
Pravastatin—CYP3A4—digestive system—systemic scleroderma	0.000213	0.0103	CbGeAlD
Pravastatin—CYP2D6—digestive system—systemic scleroderma	0.00021	0.0101	CbGeAlD
Pravastatin—Sweating increased—Prednisone—systemic scleroderma	0.000184	0.000865	CcSEcCtD
Pravastatin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000184	0.000864	CcSEcCtD
Pravastatin—Rash—Mometasone—systemic scleroderma	0.000184	0.000862	CcSEcCtD
Pravastatin—Asthenia—Captopril—systemic scleroderma	0.000183	0.000861	CcSEcCtD
Pravastatin—Dermatitis—Mometasone—systemic scleroderma	0.000183	0.000861	CcSEcCtD
Pravastatin—Decreased appetite—Leflunomide—systemic scleroderma	0.000183	0.00086	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000183	0.00086	CcSEcCtD
Pravastatin—Confusional state—Lisinopril—systemic scleroderma	0.000183	0.000857	CcSEcCtD
Pravastatin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000183	0.000857	CcSEcCtD
Pravastatin—Headache—Mometasone—systemic scleroderma	0.000182	0.000856	CcSEcCtD
Pravastatin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000855	CcSEcCtD
Pravastatin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000182	0.000854	CcSEcCtD
Pravastatin—Fatigue—Leflunomide—systemic scleroderma	0.000182	0.000853	CcSEcCtD
Pravastatin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000181	0.00085	CcSEcCtD
Pravastatin—Oedema—Lisinopril—systemic scleroderma	0.000181	0.00085	CcSEcCtD
Pravastatin—Pruritus—Captopril—systemic scleroderma	0.000181	0.00085	CcSEcCtD
Pravastatin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000181	0.000848	CcSEcCtD
Pravastatin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000847	CcSEcCtD
Pravastatin—Constipation—Leflunomide—systemic scleroderma	0.00018	0.000846	CcSEcCtD
Pravastatin—Pain—Leflunomide—systemic scleroderma	0.00018	0.000846	CcSEcCtD
Pravastatin—Infection—Lisinopril—systemic scleroderma	0.00018	0.000845	CcSEcCtD
Pravastatin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000844	CcSEcCtD
Pravastatin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000179	0.000842	CcSEcCtD
Pravastatin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000834	CcSEcCtD
Pravastatin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000177	0.000833	CcSEcCtD
Pravastatin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000177	0.000831	CcSEcCtD
Pravastatin—Body temperature increased—Azathioprine—systemic scleroderma	0.000176	0.000828	CcSEcCtD
Pravastatin—Abdominal pain—Azathioprine—systemic scleroderma	0.000176	0.000828	CcSEcCtD
Pravastatin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000823	CcSEcCtD
Pravastatin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000175	0.000822	CcSEcCtD
Pravastatin—Diarrhoea—Captopril—systemic scleroderma	0.000175	0.000822	CcSEcCtD
Pravastatin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000175	0.000821	CcSEcCtD
Pravastatin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000175	0.00082	CcSEcCtD
Pravastatin—Erectile dysfunction—Prednisone—systemic scleroderma	0.000174	0.000818	CcSEcCtD
Pravastatin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000817	CcSEcCtD
Pravastatin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000174	0.000815	CcSEcCtD
Pravastatin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000173	0.000814	CcSEcCtD
Pravastatin—Mood swings—Methotrexate—systemic scleroderma	0.000173	0.000813	CcSEcCtD
Pravastatin—Nausea—Mometasone—systemic scleroderma	0.000173	0.000812	CcSEcCtD
Pravastatin—Anorexia—Lisinopril—systemic scleroderma	0.000173	0.000811	CcSEcCtD
Pravastatin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000172	0.000809	CcSEcCtD
Pravastatin—Weight increased—Prednisone—systemic scleroderma	0.000172	0.000808	CcSEcCtD
Pravastatin—Constipation—Mycophenolic acid—systemic scleroderma	0.000172	0.000807	CcSEcCtD
Pravastatin—Pain—Mycophenolic acid—systemic scleroderma	0.000172	0.000807	CcSEcCtD
Pravastatin—Weight decreased—Prednisone—systemic scleroderma	0.000171	0.000803	CcSEcCtD
Pravastatin—Cough—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000797	CcSEcCtD
Pravastatin—Dizziness—Captopril—systemic scleroderma	0.000169	0.000794	CcSEcCtD
Pravastatin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000169	0.000793	CcSEcCtD
Pravastatin—Depression—Prednisone—systemic scleroderma	0.000168	0.00079	CcSEcCtD
Pravastatin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000788	CcSEcCtD
Pravastatin—Urticaria—Leflunomide—systemic scleroderma	0.000167	0.000786	CcSEcCtD
Pravastatin—Abdominal pain—Leflunomide—systemic scleroderma	0.000167	0.000782	CcSEcCtD
Pravastatin—Body temperature increased—Leflunomide—systemic scleroderma	0.000167	0.000782	CcSEcCtD
Pravastatin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000166	0.000781	CcSEcCtD
Pravastatin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000166	0.000778	CcSEcCtD
Pravastatin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000777	CcSEcCtD
Pravastatin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000777	CcSEcCtD
Pravastatin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000777	CcSEcCtD
Pravastatin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000165	0.000776	CcSEcCtD
Pravastatin—Myocardial infarction—Prednisone—systemic scleroderma	0.000165	0.000776	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000165	0.000775	CcSEcCtD
Pravastatin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000775	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000165	0.000773	CcSEcCtD
Pravastatin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000164	0.000772	CcSEcCtD
Pravastatin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000164	0.000772	CcSEcCtD
Pravastatin—Insomnia—Lisinopril—systemic scleroderma	0.000164	0.000769	CcSEcCtD
Pravastatin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000768	CcSEcCtD
Pravastatin—Paraesthesia—Lisinopril—systemic scleroderma	0.000163	0.000764	CcSEcCtD
Pravastatin—Vomiting—Captopril—systemic scleroderma	0.000163	0.000763	CcSEcCtD
Pravastatin—Dyspnoea—Lisinopril—systemic scleroderma	0.000161	0.000758	CcSEcCtD
Pravastatin—Rash—Captopril—systemic scleroderma	0.000161	0.000757	CcSEcCtD
Pravastatin—Dermatitis—Captopril—systemic scleroderma	0.000161	0.000756	CcSEcCtD
Pravastatin—Headache—Captopril—systemic scleroderma	0.00016	0.000752	CcSEcCtD
Pravastatin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000751	CcSEcCtD
Pravastatin—Dyspepsia—Lisinopril—systemic scleroderma	0.000159	0.000749	CcSEcCtD
Pravastatin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000159	0.000746	CcSEcCtD
Pravastatin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000159	0.000746	CcSEcCtD
Pravastatin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000745	CcSEcCtD
Pravastatin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000745	CcSEcCtD
Pravastatin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00074	CcSEcCtD
Pravastatin—Decreased appetite—Lisinopril—systemic scleroderma	0.000157	0.000739	CcSEcCtD
Pravastatin—Eosinophilia—Methotrexate—systemic scleroderma	0.000157	0.000735	CcSEcCtD
Pravastatin—Fatigue—Lisinopril—systemic scleroderma	0.000156	0.000733	CcSEcCtD
Pravastatin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000729	CcSEcCtD
Pravastatin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000155	0.000729	CcSEcCtD
Pravastatin—Pancreatitis—Methotrexate—systemic scleroderma	0.000155	0.000728	CcSEcCtD
Pravastatin—Constipation—Lisinopril—systemic scleroderma	0.000155	0.000727	CcSEcCtD
Pravastatin—Pain—Lisinopril—systemic scleroderma	0.000155	0.000727	CcSEcCtD
Pravastatin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000153	0.00072	CcSEcCtD
Pravastatin—Diarrhoea—Azathioprine—systemic scleroderma	0.000153	0.000717	CcSEcCtD
Pravastatin—Nausea—Captopril—systemic scleroderma	0.000152	0.000713	CcSEcCtD
Pravastatin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00071	CcSEcCtD
Pravastatin—Asthenia—Leflunomide—systemic scleroderma	0.000151	0.00071	CcSEcCtD
Pravastatin—ABCB1—digestive system—systemic scleroderma	0.000151	0.00727	CbGeAlD
Pravastatin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000149	0.000701	CcSEcCtD
Pravastatin—Pruritus—Leflunomide—systemic scleroderma	0.000149	0.0007	CcSEcCtD
Pravastatin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000148	0.000695	CcSEcCtD
Pravastatin—Dysuria—Methotrexate—systemic scleroderma	0.000148	0.000694	CcSEcCtD
Pravastatin—Dizziness—Azathioprine—systemic scleroderma	0.000148	0.000693	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000147	0.00069	CcSEcCtD
Pravastatin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000146	0.000684	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000679	CcSEcCtD
Pravastatin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000144	0.000677	CcSEcCtD
Pravastatin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000144	0.000677	CcSEcCtD
Pravastatin—Diarrhoea—Leflunomide—systemic scleroderma	0.000144	0.000677	CcSEcCtD
Pravastatin—Urticaria—Lisinopril—systemic scleroderma	0.000144	0.000676	CcSEcCtD
Pravastatin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000674	CcSEcCtD
Pravastatin—Abdominal pain—Lisinopril—systemic scleroderma	0.000143	0.000672	CcSEcCtD
Pravastatin—Body temperature increased—Lisinopril—systemic scleroderma	0.000143	0.000672	CcSEcCtD
Pravastatin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000669	CcSEcCtD
Pravastatin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000142	0.000668	CcSEcCtD
Pravastatin—Vomiting—Azathioprine—systemic scleroderma	0.000142	0.000666	CcSEcCtD
Pravastatin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000664	CcSEcCtD
Pravastatin—Rash—Azathioprine—systemic scleroderma	0.000141	0.000661	CcSEcCtD
Pravastatin—Dermatitis—Azathioprine—systemic scleroderma	0.000141	0.00066	CcSEcCtD
Pravastatin—Depression—Methotrexate—systemic scleroderma	0.000141	0.00066	CcSEcCtD
Pravastatin—Flushing—Prednisone—systemic scleroderma	0.000141	0.00066	CcSEcCtD
Pravastatin—Headache—Azathioprine—systemic scleroderma	0.00014	0.000656	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00014	0.000656	CcSEcCtD
Pravastatin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000656	CcSEcCtD
Pravastatin—Dizziness—Leflunomide—systemic scleroderma	0.000139	0.000654	CcSEcCtD
Pravastatin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000648	CcSEcCtD
Pravastatin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000138	0.000646	CcSEcCtD
Pravastatin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000637	CcSEcCtD
Pravastatin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000637	CcSEcCtD
Pravastatin—Arrhythmia—Prednisone—systemic scleroderma	0.000135	0.000635	CcSEcCtD
Pravastatin—Vomiting—Leflunomide—systemic scleroderma	0.000134	0.000629	CcSEcCtD
Pravastatin—Alopecia—Prednisone—systemic scleroderma	0.000134	0.000628	CcSEcCtD
Pravastatin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000133	0.000626	CcSEcCtD
Pravastatin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000133	0.000624	CcSEcCtD
Pravastatin—Rash—Leflunomide—systemic scleroderma	0.000133	0.000624	CcSEcCtD
Pravastatin—Dermatitis—Leflunomide—systemic scleroderma	0.000133	0.000623	CcSEcCtD
Pravastatin—Nausea—Azathioprine—systemic scleroderma	0.000133	0.000622	CcSEcCtD
Pravastatin—Headache—Leflunomide—systemic scleroderma	0.000132	0.00062	CcSEcCtD
Pravastatin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000614	CcSEcCtD
Pravastatin—Asthenia—Lisinopril—systemic scleroderma	0.00013	0.00061	CcSEcCtD
Pravastatin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000609	CcSEcCtD
Pravastatin—Pruritus—Lisinopril—systemic scleroderma	0.000128	0.000602	CcSEcCtD
Pravastatin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000128	0.0006	CcSEcCtD
Pravastatin—Rash—Mycophenolic acid—systemic scleroderma	0.000127	0.000595	CcSEcCtD
Pravastatin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000127	0.000595	CcSEcCtD
Pravastatin—Hepatitis—Methotrexate—systemic scleroderma	0.000127	0.000594	CcSEcCtD
Pravastatin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000592	CcSEcCtD
Pravastatin—ABCB1—lung—systemic scleroderma	0.000126	0.00607	CbGeAlD
Pravastatin—Headache—Mycophenolic acid—systemic scleroderma	0.000126	0.000591	CcSEcCtD
Pravastatin—Pharyngitis—Methotrexate—systemic scleroderma	0.000126	0.00059	CcSEcCtD
Pravastatin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000589	CcSEcCtD
Pravastatin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000589	CcSEcCtD
Pravastatin—Nausea—Leflunomide—systemic scleroderma	0.000125	0.000588	CcSEcCtD
Pravastatin—Vision blurred—Prednisone—systemic scleroderma	0.000124	0.000583	CcSEcCtD
Pravastatin—Diarrhoea—Lisinopril—systemic scleroderma	0.000124	0.000582	CcSEcCtD
Pravastatin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000122	0.000574	CcSEcCtD
Pravastatin—Visual impairment—Methotrexate—systemic scleroderma	0.000122	0.000572	CcSEcCtD
Pravastatin—Anaemia—Prednisone—systemic scleroderma	0.000122	0.000572	CcSEcCtD
Pravastatin—Angioedema—Prednisone—systemic scleroderma	0.00012	0.000565	CcSEcCtD
Pravastatin—Dizziness—Lisinopril—systemic scleroderma	0.00012	0.000562	CcSEcCtD
Pravastatin—Erythema multiforme—Methotrexate—systemic scleroderma	0.00012	0.000562	CcSEcCtD
Pravastatin—Nausea—Mycophenolic acid—systemic scleroderma	0.000119	0.000561	CcSEcCtD
Pravastatin—Malaise—Prednisone—systemic scleroderma	0.000119	0.000558	CcSEcCtD
Pravastatin—Vertigo—Prednisone—systemic scleroderma	0.000118	0.000556	CcSEcCtD
Pravastatin—Tinnitus—Methotrexate—systemic scleroderma	0.000118	0.000554	CcSEcCtD
Pravastatin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000117	0.000551	CcSEcCtD
Pravastatin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000549	CcSEcCtD
Pravastatin—Vomiting—Lisinopril—systemic scleroderma	0.000115	0.000541	CcSEcCtD
Pravastatin—Rash—Lisinopril—systemic scleroderma	0.000114	0.000536	CcSEcCtD
Pravastatin—Dermatitis—Lisinopril—systemic scleroderma	0.000114	0.000536	CcSEcCtD
Pravastatin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000535	CcSEcCtD
Pravastatin—Hypertension—Prednisone—systemic scleroderma	0.000114	0.000534	CcSEcCtD
Pravastatin—Chills—Methotrexate—systemic scleroderma	0.000114	0.000533	CcSEcCtD
Pravastatin—Headache—Lisinopril—systemic scleroderma	0.000113	0.000533	CcSEcCtD
Pravastatin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000527	CcSEcCtD
Pravastatin—Myalgia—Prednisone—systemic scleroderma	0.000112	0.000527	CcSEcCtD
Pravastatin—Arthralgia—Prednisone—systemic scleroderma	0.000112	0.000527	CcSEcCtD
Pravastatin—Anxiety—Prednisone—systemic scleroderma	0.000112	0.000525	CcSEcCtD
Pravastatin—Alopecia—Methotrexate—systemic scleroderma	0.000112	0.000525	CcSEcCtD
Pravastatin—Discomfort—Prednisone—systemic scleroderma	0.000111	0.000521	CcSEcCtD
Pravastatin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000109	0.00051	CcSEcCtD
Pravastatin—Dysgeusia—Methotrexate—systemic scleroderma	0.000108	0.000506	CcSEcCtD
Pravastatin—Nausea—Lisinopril—systemic scleroderma	0.000108	0.000505	CcSEcCtD
Pravastatin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000108	0.000505	CcSEcCtD
Pravastatin—Oedema—Prednisone—systemic scleroderma	0.000108	0.000505	CcSEcCtD
Pravastatin—Infection—Prednisone—systemic scleroderma	0.000107	0.000502	CcSEcCtD
Pravastatin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000493	CcSEcCtD
Pravastatin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000104	0.000488	CcSEcCtD
Pravastatin—Vision blurred—Methotrexate—systemic scleroderma	0.000104	0.000487	CcSEcCtD
Pravastatin—Anorexia—Prednisone—systemic scleroderma	0.000103	0.000481	CcSEcCtD
Pravastatin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000102	0.00048	CcSEcCtD
Pravastatin—Anaemia—Methotrexate—systemic scleroderma	0.000102	0.000478	CcSEcCtD
Pravastatin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000474	CcSEcCtD
Pravastatin—Rash—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00047	CcSEcCtD
Pravastatin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000469	CcSEcCtD
Pravastatin—Headache—Mycophenolate mofetil—systemic scleroderma	9.94e-05	0.000467	CcSEcCtD
Pravastatin—Malaise—Methotrexate—systemic scleroderma	9.93e-05	0.000466	CcSEcCtD
Pravastatin—Vertigo—Methotrexate—systemic scleroderma	9.9e-05	0.000465	CcSEcCtD
Pravastatin—Leukopenia—Methotrexate—systemic scleroderma	9.86e-05	0.000463	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.8e-05	0.00046	CcSEcCtD
Pravastatin—Insomnia—Prednisone—systemic scleroderma	9.73e-05	0.000457	CcSEcCtD
Pravastatin—Paraesthesia—Prednisone—systemic scleroderma	9.66e-05	0.000453	CcSEcCtD
Pravastatin—Cough—Methotrexate—systemic scleroderma	9.61e-05	0.000451	CcSEcCtD
Pravastatin—Dyspepsia—Prednisone—systemic scleroderma	9.47e-05	0.000445	CcSEcCtD
Pravastatin—Nausea—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.000443	CcSEcCtD
Pravastatin—Chest pain—Methotrexate—systemic scleroderma	9.38e-05	0.00044	CcSEcCtD
Pravastatin—Arthralgia—Methotrexate—systemic scleroderma	9.38e-05	0.00044	CcSEcCtD
Pravastatin—Myalgia—Methotrexate—systemic scleroderma	9.38e-05	0.00044	CcSEcCtD
Pravastatin—Decreased appetite—Prednisone—systemic scleroderma	9.35e-05	0.000439	CcSEcCtD
Pravastatin—Fatigue—Prednisone—systemic scleroderma	9.27e-05	0.000435	CcSEcCtD
Pravastatin—Discomfort—Methotrexate—systemic scleroderma	9.26e-05	0.000435	CcSEcCtD
Pravastatin—Constipation—Prednisone—systemic scleroderma	9.2e-05	0.000432	CcSEcCtD
Pravastatin—Confusional state—Methotrexate—systemic scleroderma	9.06e-05	0.000426	CcSEcCtD
Pravastatin—Anaphylactic shock—Methotrexate—systemic scleroderma	8.99e-05	0.000422	CcSEcCtD
Pravastatin—Infection—Methotrexate—systemic scleroderma	8.93e-05	0.000419	CcSEcCtD
Pravastatin—Feeling abnormal—Prednisone—systemic scleroderma	8.86e-05	0.000416	CcSEcCtD
Pravastatin—Thrombocytopenia—Methotrexate—systemic scleroderma	8.8e-05	0.000413	CcSEcCtD
Pravastatin—Gastrointestinal pain—Prednisone—systemic scleroderma	8.8e-05	0.000413	CcSEcCtD
Pravastatin—Hyperhidrosis—Methotrexate—systemic scleroderma	8.69e-05	0.000408	CcSEcCtD
Pravastatin—Anorexia—Methotrexate—systemic scleroderma	8.57e-05	0.000402	CcSEcCtD
Pravastatin—Urticaria—Prednisone—systemic scleroderma	8.54e-05	0.000401	CcSEcCtD
Pravastatin—Abdominal pain—Prednisone—systemic scleroderma	8.5e-05	0.000399	CcSEcCtD
Pravastatin—Body temperature increased—Prednisone—systemic scleroderma	8.5e-05	0.000399	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.19e-05	0.000385	CcSEcCtD
Pravastatin—Insomnia—Methotrexate—systemic scleroderma	8.13e-05	0.000382	CcSEcCtD
Pravastatin—Paraesthesia—Methotrexate—systemic scleroderma	8.07e-05	0.000379	CcSEcCtD
Pravastatin—Dyspnoea—Methotrexate—systemic scleroderma	8.01e-05	0.000376	CcSEcCtD
Pravastatin—Hypersensitivity—Prednisone—systemic scleroderma	7.92e-05	0.000372	CcSEcCtD
Pravastatin—Dyspepsia—Methotrexate—systemic scleroderma	7.91e-05	0.000372	CcSEcCtD
Pravastatin—Decreased appetite—Methotrexate—systemic scleroderma	7.81e-05	0.000367	CcSEcCtD
Pravastatin—Fatigue—Methotrexate—systemic scleroderma	7.75e-05	0.000364	CcSEcCtD
Pravastatin—Asthenia—Prednisone—systemic scleroderma	7.72e-05	0.000362	CcSEcCtD
Pravastatin—Pain—Methotrexate—systemic scleroderma	7.69e-05	0.000361	CcSEcCtD
Pravastatin—Pruritus—Prednisone—systemic scleroderma	7.61e-05	0.000357	CcSEcCtD
Pravastatin—Feeling abnormal—Methotrexate—systemic scleroderma	7.41e-05	0.000348	CcSEcCtD
Pravastatin—Diarrhoea—Prednisone—systemic scleroderma	7.36e-05	0.000346	CcSEcCtD
Pravastatin—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.35e-05	0.000345	CcSEcCtD
Pravastatin—Urticaria—Methotrexate—systemic scleroderma	7.14e-05	0.000335	CcSEcCtD
Pravastatin—Dizziness—Prednisone—systemic scleroderma	7.11e-05	0.000334	CcSEcCtD
Pravastatin—Abdominal pain—Methotrexate—systemic scleroderma	7.11e-05	0.000334	CcSEcCtD
Pravastatin—Body temperature increased—Methotrexate—systemic scleroderma	7.11e-05	0.000334	CcSEcCtD
Pravastatin—Vomiting—Prednisone—systemic scleroderma	6.84e-05	0.000321	CcSEcCtD
Pravastatin—Rash—Prednisone—systemic scleroderma	6.78e-05	0.000318	CcSEcCtD
Pravastatin—Dermatitis—Prednisone—systemic scleroderma	6.78e-05	0.000318	CcSEcCtD
Pravastatin—Headache—Prednisone—systemic scleroderma	6.74e-05	0.000316	CcSEcCtD
Pravastatin—Hypersensitivity—Methotrexate—systemic scleroderma	6.62e-05	0.000311	CcSEcCtD
Pravastatin—Asthenia—Methotrexate—systemic scleroderma	6.45e-05	0.000303	CcSEcCtD
Pravastatin—Nausea—Prednisone—systemic scleroderma	6.39e-05	0.0003	CcSEcCtD
Pravastatin—Pruritus—Methotrexate—systemic scleroderma	6.36e-05	0.000299	CcSEcCtD
Pravastatin—Diarrhoea—Methotrexate—systemic scleroderma	6.15e-05	0.000289	CcSEcCtD
Pravastatin—Dizziness—Methotrexate—systemic scleroderma	5.94e-05	0.000279	CcSEcCtD
Pravastatin—Vomiting—Methotrexate—systemic scleroderma	5.72e-05	0.000268	CcSEcCtD
Pravastatin—Rash—Methotrexate—systemic scleroderma	5.67e-05	0.000266	CcSEcCtD
Pravastatin—Dermatitis—Methotrexate—systemic scleroderma	5.66e-05	0.000266	CcSEcCtD
Pravastatin—Headache—Methotrexate—systemic scleroderma	5.63e-05	0.000264	CcSEcCtD
Pravastatin—Nausea—Methotrexate—systemic scleroderma	5.34e-05	0.000251	CcSEcCtD
